Zdrowie i gospodarka · 28/07/2003

FDA Classifies Breast Lesion Documentation System into Class II Special Controls

The FDA is classifying the breast lesion documentation system into Class II special controls to ensure a reasonable assurance of safety and effectiveness, following a petition submitted under the Federal Food, Drug, and Cosmetic Act and other amendments.